Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04926831
Title Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC (Geometry-N)
Acronym Geometry-N
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.